CD276 and colorectal cancer: In colorectal cancer, B7H3 promotes tum or growth and cell viability, modulates the inflammatory response, enhances chemoresistance to oxaliplatin and 5-FU and radio resistance via the B7-H3/KIF15/ERK axis pathway, and inhibits apoptosis [16,17,18,19].